Bicocca Open Archive

Logo unimib boa
CAIROLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 861
EU - Europa 770
AS - Asia 425
SA - Sud America 25
AF - Africa 11
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 844
IT - Italia 378
HK - Hong Kong 275
DE - Germania 102
CN - Cina 72
GB - Regno Unito 70
SE - Svezia 61
BE - Belgio 45
FI - Finlandia 31
IN - India 28
UA - Ucraina 21
BR - Brasile 20
NL - Olanda 17
CA - Canada 15
ES - Italia 11
IE - Irlanda 10
VN - Vietnam 10
FR - Francia 9
JP - Giappone 9
CH - Svizzera 6
IL - Israele 5
NP - Nepal 5
SA - Arabia Saudita 5
AU - Australia 4
CO - Colombia 4
IR - Iran 3
SG - Singapore 3
TR - Turchia 3
ZA - Sudafrica 3
AM - Armenia 2
EG - Egitto 2
HR - Croazia 2
ID - Indonesia 2
MA - Marocco 2
MX - Messico 2
PL - Polonia 2
SI - Slovenia 2
TW - Taiwan 2
UG - Uganda 2
AR - Argentina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EU - Europa 1
GH - Ghana 1
KR - Corea 1
NZ - Nuova Zelanda 1
RO - Romania 1
TN - Tunisia 1
Totale 2.098
Salva come PNG Salva come JPEG
Città #
Hong Kong 272
New York 204
Ann Arbor 124
Ashburn 110
Milan 89
Frankfurt am Main 78
Fairfield 46
Brussels 42
Chandler 41
Turin 35
London 29
Helsinki 24
Washington 24
Houston 22
Seattle 22
Jacksonville 19
Princeton 18
Wilmington 18
Rome 17
Dearborn 16
Woodbridge 13
Cambridge 12
Phoenix 12
São Paulo 12
Bologna 11
Boardman 10
Chiswick 10
Dublin 10
Naples 10
Altamura 9
Lawrence 9
San Diego 9
Groningen 8
Mumbai 8
Nanjing 8
Beijing 7
Hyderabad 7
Orbassano 7
Desio 6
Amsterdam 5
Chengdu 5
Corsico 5
Rocca Canavese 5
Shanghai 5
Tel Aviv 5
Biratnagar 4
Guangzhou 4
Hangzhou 4
Lappeenranta 4
Madrid 4
Padova 4
Palermo 4
Perugia 4
Torre Annunziata 4
Aalst 3
Alatri 3
Arezzo 3
Bari 3
Beauharnois 3
Burlington 3
Cantu 3
Central 3
Changchun 3
Falls Church 3
Jalgaon 3
Johannesburg 3
Lachine 3
Montreal 3
Monza 3
Mountain View 3
Sedico 3
Shiraz 3
Siziano 3
Sydney 3
Taunton 3
Toronto 3
Verona 3
Acquanegra sul Chiese 2
Alba 2
Andover 2
Arzachena 2
Auburn Hills 2
Aulla 2
Bacoli 2
Bergamo 2
Berzo Inferiore 2
Bethesda 2
Birmingham 2
Brescia 2
Brookline 2
Buffalo 2
Cascina 2
Castelfidardo 2
Catania 2
Cham 2
Changsha 2
Chia 2
Como 2
Coventry 2
Düsseldorf 2
Totale 1.609
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 138
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia 127
The role of quantitative polymerase chain reaction in the management of follicular lymphoma patients 115
Impact of serial echocardiography in the management of primary cardiac lymphoma 112
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 109
Assessing eligibility for treatment in acute myeloid leukemia in 2023 96
KIT activating mutations: Incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication 86
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 59
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review 55
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities 39
A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms 27
How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia 25
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 25
MIS-A: Beware of non-lymphoma 21
"Efficient Strategies for the Reuse of Surgical and FFP2/ KN95 Face Masks during the COVID-19 Pandemic: Home-Made and Ecological Choices for the Community" 20
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis 19
Intrahospital COVID-19 infection outbreak management: Keep calm and carry on 19
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 18
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 17
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study 16
Identification of genes differently expressed between bone marrow CD34+/LIN-cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs 12 months of first-line nilotinib treatment 16
RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP 15
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia 15
IN ADULT ACUTE MYELOID LEUKEMIA (AML) PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE (MRD) BY FLOW CYTOMETRY (FC) IS FEASIBLE AND IS PROGNOSTICALLY RELEVANT 15
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study 15
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 15
Arg expression studied in normal human leukocytes and in leukemic cells by RT-PCR 15
Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 15
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination? 14
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 14
Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization 14
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 13
Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation 12
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: Results of an Italian multicenter study 12
Use of Sorafenib in FLT3-Mutant Myeloid Sarcoma: A Case Report 12
VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL 12
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy 12
Prognostic significance of CD33, CD34 and CD117 expression on bone marrow blasts of patients with Myelodysplastic syndromes 12
"MOLTO", A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB (AVO) COMBINATION IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS 11
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index 11
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H 11
Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation 11
Is HBV prophylaxis required during CLL treatment with ibrutinib? 11
IDENTIFICAZIONE DI MIRNA E GENI TARGET NELL’ANALISI TRASCRITTOMICA DELLE CELLULE CD34+/LIN- DI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN FASE CRONICA DOPO 12 MESI DI TERAPIA CON NILOTINIB 11
c-kit activating mutations and mast cell proliferation in human leukemia [4] 11
Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection 11
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia 10
Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT 10
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation 10
Targeted Therapy in FLT3-ITD Positive Myeloid Sarcoma: Proof of Principle 10
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 10
Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era 10
Myeloma’s multiple morphologies 9
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 9
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913 9
Complications at insertion of untunnelled central venous catheters (UCVCs) in leukemic patients at a high risk of hemorrhage 9
A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry 9
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 9
Decisional Role of Interim PET in Relapsed/Refractory Classical Hodgkin Lymphoma Treated with Begev Chemotherapy As First Salvage 9
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 9
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study 9
The ERK1/2 Regulator WNK2 Shows Novel Alternative Splicing Aberrations That Support Tumor Growth in MYD88 Mutated Waldenstrom's Macroglobulinemia 9
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study 9
Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta 9
SEQUENTIAL USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ADULT PRIMARY IMMUNE THROMBOCYTOPENIA PATIENTS: A RETROSPECTIVE COLLABORATIVE SURVEY FROM ITALIAN HEMATOLOGY CENTERS 9
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 9
PH plus STEM CELLS (SCS) IN CHRONIC MYELOID LEUKEMIA (CML): TO ERADICATE OR NOT TO ERADICATE, THIS IS THE QUESTION 9
Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia 9
ACUTE PROMYELOCYTIC LEUKEMIA - COMPLETE REMISSION AND BONE-MARROW TRANSPLANTATION FOLLOW-UP MONITORED BY POLYMERASE CHAIN-REACTION 9
Acute leukemia and high-risk myelodysplastic syndromes in hiv positive patients: 25-years' experience of the rete ematologica lombarda (REL) 9
FZD6 triggers Wnt–signalling driven by WNT10BIVS1 expression and highlights new targets in T-cell acute lymphoblastic leukemia 9
Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia 9
Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol 9
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 9
CLINICAL RELEVANCE OF RECURRENT ALLELE-SPECIFIC RECOMBINATION EXPRESSING THE WNT10BIVS1 ALLELE VARIANT IN ACUTE MYELOID LEUKEMIA 9
Efficacy and safety of Sti571 (glivec) in two patients with CML blast crisis (BC) occurring after bonemarrow transplantation (BMT) and submitted to a second transplant procedure 9
Results of MOLTO, a multicenter, open label, phase II clinical trial evaluating venetoclax, atezolizumab and obinutuzumab combination in Richter syndrome 8
Sequential subcutaneous administration of Campath-1H as treatment of minimal residual disease in CLL patients responding to fludarabine (FAMP) 8
Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis 8
Use of Plerixafor in Poor Mobilizer Patients with Myeloma and Lymphoma: Clonogenic Capacity and Engraftment Data 8
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation 8
Administration of plerixafor in poor mobilizers allows mobilization of haematopoietic progenitors: Clonogenic potential and engraftment analysis 8
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment 8
PLASMA VON-WILLEBRAND-FACTOR MULTIMERIC ANALYSIS IN AUTOLOGOUS (ABMT) AND ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) 8
Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia 8
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 8
Quantitative PCR survey of chronic myelogenous leukemia (CML) transplanted patients 8
Molecular follow-up with qualitative and competitive PCR in patients affected by follicular lymphoma before and after auto or allo stem cell transplantation 8
Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes 8
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents? 8
Multidimensional Results and Reflections on CAR-T: The Italian Evidence 8
Safety and efficacy of NEPA and dexamethasone in Hodgkin's lymphoma patients: a single-center real-life experience 8
New Insights from CAR-T: An Economic and Organizational Perspective 8
High dose etoposide and cyclophosphamide (HD-VP/CTX) as salvage treatment for all patients 8
Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience 8
Prognostic value of circulating CD34+ cells in myelodysplastic syndromes 8
LABNET AML: AN EFFICIENT NETWORK THAT CONNECTS HEMATOLOGY CENTERS AND LABORATORIES FOR A HIGH-LEVEL DIAGNOSTIC/PROGNOSTIC WORKUP OF AML 8
Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial (Experimental Hematology & Oncology, (2021), 10, 1, (14), 10.1186/s40164-021-00210-9) 8
VENETOCLAX IN MULTI-RELAPSED MANTLE CELL LYMPHOMA PATIENTS: A REAL-LIFE MULTICENTRIC EXPERIENCE 7
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy? 7
Totale 1.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 5 2 0 1 5 15 13
2019/202094 13 2 6 9 9 16 13 7 8 4 4 3
2020/2021141 3 3 40 14 15 11 12 12 14 6 3 8
2021/2022121 6 3 15 7 11 10 2 14 7 8 12 26
2022/20231.459 27 57 11 13 9 26 2 182 61 920 69 82
2023/20241.056 57 118 144 105 515 117 0 0 0 0 0 0
Totale 2.987